<https://bcan.org/clinicaltrials/ngm831-as-monotherapy-and-in-combination-with-pembrolizumab-in-advanced-or-metastatic-solid-tumors/>
<http://schema.org/description>
"NGM831 as Monotherapy and in Combination with Pembrolizumab in Advanced or Metastatic Solid Tumors including advanced urothelial carcinoma."
<https://bcan.org/clinicaltrials/ngm831-as-monotherapy-and-in-combination-with-pembrolizumab-in-advanced-or-metastatic-solid-tumors/>